Physicochemical characterisation of a drug-containing phospholipid-stabilised o/w emulsion for intravenous administration

被引:43
作者
Nordén, TP
Siekmann, B
Lundquist, S
Malmsten, M
机构
[1] AstraZeneca R&D Sodertalje, SE-15185 Sodertalje, Sweden
[2] Inst Surface Chem, YKI, S-11486 Stockholm, Sweden
[3] Royal Inst Technol, Dept Chem, SE-10044 Stockholm, Sweden
关键词
clomethiazole; drug-lipid interaction; nuclear magnetic resonance; o/w emulsion; phospholipid; photon correlation spectroscopy;
D O I
10.1016/S0928-0987(01)00138-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Clomethiazole (CMZ) was used as a model drug to be incorporated into an emulsion vehicle. The effects of drug concentration and number of homogenisation steps were evaluated using multiple linear regression. The droplet size, measured as a z-average diameter by photon correlation spectroscopy (PCS), was found to be between 60 and 260 nm in the investigated range of CMZ concentrations, highly dependent on the concentration, but more weakly so on the number of homogenisation steps. Slow-scanning high-sensitivity differential scanning calorimetry (DSC) measurements showed that CMZ depresses the phospholipid chain melting temperature in the emulsion system, whereas C-13 nuclear magnetic resonance (NMR) experiments suggested that the CMZ molecules are to a large extent located in the surface region of the emulsion droplets. This interpretation is compatible with results from NMR self-diffusion measurements, which showed that most of the CMZ molecules are rapidly exchanged between emulsion droplets and the aqueous surrounding. It can be concluded that the surface-active drug CMZ has a significant influence on the characteristics of phospholipid-stabilised emulsions through its ability to interact with the phospholipid interface. Thus, the results underline the importance of characterising drug-lipid interactions for the development of lipid-based formulations. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:393 / 401
页数:9
相关论文
共 35 条
[1]  
[Anonymous], 1993, PHOSPHOLIPID HDB
[2]  
BABL J, 1995, EUR HOSP PHARM, V1, P15
[3]   Diffusion of the dispersed phase in a highly concentrated emulsion: Emulsion structure and film permeation [J].
Balinov, B ;
Linse, P ;
Soderman, O .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1996, 182 (02) :539-548
[4]   CONTROLLED ENVIRONMENT VITRIFICATION SYSTEM - AN IMPROVED SAMPLE PREPARATION TECHNIQUE [J].
BELLARE, JR ;
DAVIS, HT ;
SCRIVEN, LE ;
TALMON, Y .
JOURNAL OF ELECTRON MICROSCOPY TECHNIQUE, 1988, 10 (01) :87-111
[5]   PHYSOSTIGMINE EMULSION - A NEW INJECTABLE CONTROLLED RELEASE DELIVERY SYSTEM [J].
BENITA, S ;
FRIEDMAN, D ;
WEINSTOCK, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 30 (01) :47-55
[6]   The influence of alkali fatty acids on the properties and the stability of parenteral O/W emulsions modified with Solutol HS 15® [J].
Buszello, K ;
Harnisch, S ;
Müller, RH ;
Müller, BW .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 49 (02) :143-149
[7]  
COLLINS-GOLD L C, 1990, Advanced Drug Delivery Reviews, V5, P189, DOI 10.1016/0169-409X(90)90016-L
[8]   Aggregation and microstructure in aqueous solutions of the nonionic surfactant C(12)E(8) [J].
Danino, D ;
Talmon, Y ;
Zana, R .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1997, 186 (01) :170-179
[9]   Vesicle-to-micelle transformation in systems containing dimeric surfactants [J].
Danino, D ;
Talmon, Y ;
Zana, R .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1997, 185 (01) :84-93
[10]   Ostwald ripening in the transient regime: A Cryo-TEM study [J].
De Smet, Y ;
Danino, D ;
Deriemaeker, L ;
Talmon, Y ;
Finsy, R .
LANGMUIR, 2000, 16 (03) :961-967